Walleye Capital LLC 10x Genomics, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

A detailed history of Walleye Capital LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 9,910 shares of TXG stock, worth $141,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,910
Previous 51,100 80.61%
Holding current value
$141,812
Previous $993,000 77.54%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.71 - $23.49 $44,742 - $66,899
-2,848 Reduced 22.32%
9,910 $223,000
Q2 2024

Aug 14, 2024
BUY
$19.45 - $37.37 $119,014 - $228,667
6,119 Added 92.17%
12,758 $248,000
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $239,535 - $360,497
6,639 New
6,639 $249,000
Q3 2023

Nov 14, 2023
BUY
$40.86 - $62.98 $648,570 - $999,681
15,873 Added 1178.4%
17,220 $710,000
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $68,643 - $79,095
1,347 New
1,347 $75,000
Q3 2021

Nov 15, 2021
SELL
$145.58 - $192.14 $511,859 - $675,564
-3,516 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$134.22 - $202.37 $161,332 - $243,248
-1,202 Reduced 25.48%
3,516 $689,000
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $897,039 - $1.26 Million
-6,396 Reduced 57.55%
4,718 $854,000
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $282,028 - $365,051
2,230 Added 25.1%
11,114 $1.57 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $564,949 - $807,625
6,461 Added 266.65%
8,884 $1.11 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $141,478 - $216,398
2,423 New
2,423 $216,000

Others Institutions Holding TXG

# of Institutions
290
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email